RICHARDSON, Texas, Oct. 19 /PRNewswire/ -- Zyvex today announced financial
results for its fiscal 2005 3rd quarter. The Texas Company continues its
business gains with total revenues for the third quarter totaling $2.6 million
-- a 36 percent increase over the same period in 2004. The company's
NanoSolve(TM) materials product line revenues increased 183 percent over the
same period in 2004.
"Solid execution contributed to another quarter of financial and
operational results," said Zyvex CFO Timothy M. Gilmore. "During the month of
September, we recorded our third largest single month of customer orders
booked, as well as net sales recorded."
"Our NanoSolve Materials product line, which recently won an R&D 100
award, is receiving considerable interest from customers around the world,"
said Zyvex President Dr. Tom Cellucci. "Combined with our NanoWorks(R) Tools
products, we now provide a wide range of solutions for real-world
applications. We expect to meet or beat our plan for the 4th quarter and
generate a substantial order backlog going into 2006."
Zyvex also announced that it has signed Coherent Scientific Pty. Ltd.,
Inc. as its exclusive distributor for its NanoWorks Tools and NanoLock(TM)
Structures product lines in Australia and New Zealand. Coherent Scientific
specializes in the marketing, sale, importation, commissioning and support of
laser, microscopes and other optics related equipment to the physical
sciences, life sciences, commercial, defense and telecommunications markets.
Zyvex also has worldwide sales representation in China, France, Germany,
Italy, Japan, Korea, Malaysia, Poland, Singapore, Switzerland, Taiwan,
Thailand, the United Kingdom, and Vietnam through alliances with Keithley
Instruments, Inc., Caltron, Pte., and L.O.T.-Oriel. The company has numerous
key alliances with industry leaders, including Easton Sports, FEI Company,
Frost & Sullivan, and MANCEF, and universities, including MIT's Institute for
Soldier Nanotechnologies and the University of Louisville.
Founded in 1997, Zyvex reported its first revenues in 2001, grossing
$150,000. Company revenue grew to $1.2 million in 2002, $4.3 million in 2003,
and $8.6 million in 2004. Gilmore anticipates that the company will exceed
$10 million in revenue during 2005, achieve cash-flow break-even by Q1 2006,
and become bottom-line profitable by the end of 2006.
About the Company
Zyvex Corporation, based in Richardson, Texas, is the first molecular
nanotechnology company. Zyvex's vision is to be the leading worldwide supplier
of tools, products, and services that enable adaptable, affordable, and
molecularly precise manufacturing. Zyvex commercializes nanotechnology to
address real-world applications with high growth potential. Zyvex carries its
scientific breakthroughs into key commercial applications in the area of
materials, tools, and structures.
SOURCE Zyvex Corporation